
Aditi Dutt
Examiner (ID: 3991)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1675, 1649 |
| Total Applications | 617 |
| Issued Applications | 221 |
| Pending Applications | 75 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7657332
[patent_doc_number] => 20110306601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/213419
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29741
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306601.pdf
[firstpage_image] =>[orig_patent_app_number] => 13213419
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/213419 | PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION | Aug 18, 2011 | Abandoned |
Array
(
[id] => 7719831
[patent_doc_number] => 20120009166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Isolated monocyte populations and related therapeutic applications'
[patent_app_type] => utility
[patent_app_number] => 13/136940
[patent_app_country] => US
[patent_app_date] => 2011-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12302
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009166.pdf
[firstpage_image] =>[orig_patent_app_number] => 13136940
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/136940 | Isolated monocyte populations and related therapeutic applications | Aug 14, 2011 | Abandoned |
Array
(
[id] => 7754811
[patent_doc_number] => 20120027848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use'
[patent_app_type] => utility
[patent_app_number] => 13/193346
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17725
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13193346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/193346 | Enzyme delivery systems and methods of preparation and use | Jul 27, 2011 | Issued |
Array
(
[id] => 7754811
[patent_doc_number] => 20120027848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use'
[patent_app_type] => utility
[patent_app_number] => 13/193346
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17725
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13193346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/193346 | Enzyme delivery systems and methods of preparation and use | Jul 27, 2011 | Issued |
Array
(
[id] => 7754811
[patent_doc_number] => 20120027848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use'
[patent_app_type] => utility
[patent_app_number] => 13/193346
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17725
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13193346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/193346 | Enzyme delivery systems and methods of preparation and use | Jul 27, 2011 | Issued |
Array
(
[id] => 7754811
[patent_doc_number] => 20120027848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use'
[patent_app_type] => utility
[patent_app_number] => 13/193346
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17725
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13193346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/193346 | Enzyme delivery systems and methods of preparation and use | Jul 27, 2011 | Issued |
Array
(
[id] => 8653203
[patent_doc_number] => 08372953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/181387
[patent_app_country] => US
[patent_app_date] => 2011-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9290
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13181387
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/181387 | Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof | Jul 11, 2011 | Issued |
Array
(
[id] => 8858391
[patent_doc_number] => 08460925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Methods for culturing mammalian taste cells'
[patent_app_type] => utility
[patent_app_number] => 13/180911
[patent_app_country] => US
[patent_app_date] => 2011-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11900
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180911
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/180911 | Methods for culturing mammalian taste cells | Jul 11, 2011 | Issued |
Array
(
[id] => 8792079
[patent_doc_number] => 20130109048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'METHOD FOR IN-VITRO MONITORING OF NEURONAL DISORDERS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/809315
[patent_app_country] => US
[patent_app_date] => 2011-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11974
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809315
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809315 | METHOD FOR IN-VITRO MONITORING OF NEURONAL DISORDERS AND USE THEREOF | Jul 10, 2011 | Abandoned |
Array
(
[id] => 8903674
[patent_doc_number] => 20130171177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Therapeutic Use of Neural Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 13/701932
[patent_app_country] => US
[patent_app_date] => 2011-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5191
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701932 | Therapeutic use of neural stem cells | Jul 10, 2011 | Issued |
Array
(
[id] => 7720813
[patent_doc_number] => 20120010148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'COMBINATION THERAPIES USING NAP'
[patent_app_type] => utility
[patent_app_number] => 13/174167
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25346
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010148.pdf
[firstpage_image] =>[orig_patent_app_number] => 13174167
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/174167 | COMBINATION THERAPIES USING NAP | Jun 29, 2011 | Abandoned |
Array
(
[id] => 11219137
[patent_doc_number] => 09447466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Method for determination or evaluation of test substance'
[patent_app_type] => utility
[patent_app_number] => 13/806979
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 7798
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806979
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806979 | Method for determination or evaluation of test substance | Jun 22, 2011 | Issued |
Array
(
[id] => 8814167
[patent_doc_number] => 20130115212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors'
[patent_app_type] => utility
[patent_app_number] => 13/702692
[patent_app_country] => US
[patent_app_date] => 2011-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21435
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702692
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/702692 | Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors | Jun 13, 2011 | Abandoned |
Array
(
[id] => 9530010
[patent_doc_number] => 08753881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Method for inducing differentiation of mesenchymal stem cells to nerve cells using sound waves'
[patent_app_type] => utility
[patent_app_number] => 13/702982
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 4422
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/702982 | Method for inducing differentiation of mesenchymal stem cells to nerve cells using sound waves | Jun 7, 2011 | Issued |
Array
(
[id] => 8509146
[patent_doc_number] => 20120308554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'VEGF-D/VEGFR2/3-MEDIATED REGULATION OF DENDRITES'
[patent_app_type] => utility
[patent_app_number] => 13/150846
[patent_app_country] => US
[patent_app_date] => 2011-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 13239
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13150846
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/150846 | VEGF-D/VEGFR2/3-MEDIATED REGULATION OF DENDRITES | May 31, 2011 | Abandoned |
Array
(
[id] => 6087779
[patent_doc_number] => 20110217264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVIOUS SYSTEM SITES'
[patent_app_type] => utility
[patent_app_number] => 13/108552
[patent_app_country] => US
[patent_app_date] => 2011-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20148
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217264.pdf
[firstpage_image] =>[orig_patent_app_number] => 13108552
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/108552 | METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVIOUS SYSTEM SITES | May 15, 2011 | Abandoned |
Array
(
[id] => 8829944
[patent_doc_number] => 20130130989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'EIF4E BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/695011
[patent_app_country] => US
[patent_app_date] => 2011-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15020
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/695011 | eIF4E binding peptides | Apr 26, 2011 | Issued |
Array
(
[id] => 8638195
[patent_doc_number] => 20130029998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/640545
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4344
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640545 | Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases | Apr 20, 2011 | Abandoned |
Array
(
[id] => 6187578
[patent_doc_number] => 20110171128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'APROTININ POLYPEPTIDES FOR TRANSPORTING A COMPOUND ACROSS THE BLOOD-BRAIN BARRIER'
[patent_app_type] => utility
[patent_app_number] => 13/042017
[patent_app_country] => US
[patent_app_date] => 2011-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19525
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171128.pdf
[firstpage_image] =>[orig_patent_app_number] => 13042017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/042017 | Aprotinin polypeptides for transporting a compound across the blood-brain barrier | Mar 6, 2011 | Issued |
Array
(
[id] => 9827942
[patent_doc_number] => 08937169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-20
[patent_title] => 'Human G-protein chemokine receptor HSATU68'
[patent_app_type] => utility
[patent_app_number] => 13/018300
[patent_app_country] => US
[patent_app_date] => 2011-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 160561
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13018300
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/018300 | Human G-protein chemokine receptor HSATU68 | Jan 30, 2011 | Issued |